This invention relates to novel indazole derivatives of formula I:
wherein R
1
to R
7
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are FXR modulators and can be used as medicaments.
这项发明涉及公式I的新型
吲唑衍
生物:
其中R1至R7如描述和索赔中所定义,以及其生理上可接受的盐。这些化合物是FXR调节剂,可用作药物。